• Home
  • Access
JAPANESE
  • Technologies
  • Products
  • About PSS
  • Investor Relations
  • FAQ / Contact

Home > About PSS > Corporate Profile > History

About PSS

History

Establishment : 1985 to 1994
Christian Era Month Description
1985 July 17 Founded as a maintenance and service company for clinical laboratory instruments at Itabashi-Ku, Tokyo.
1986 September The Head Office was transferred to Fuchu-city, Tokyo.
1989 February Starting the production and sales of clinical laboratory instruments such as fractionating devices, dilution apparatuses and washing apparatuses started as PSS own products.
1991 February Matsudo Research Laboratory was founded in Matsudo, Chiba, as a research and development facility.
1993 January The Head Office was transferred to Inagi-city, Tokyo.
Establishment of business model : 1995 to 2000
Christian Era Month Description
1995 June Successfully commercialized the immunochemical luminescence measuring system (HiMICO) using magnetic particles technology. The invented technology was applied for patent in various countries including Japan, U.S., and Europe, and was named "Magtration® Technology"
October Successfully commercialized the automated DNA extraction system using the Magtration® Technology.
1996 August Entered an OEM contract as for Automated DNA extraction system and others with TOYOBO. Co., Ltd. (JAPAN).
1997 November Entered an OEM contract as for Automated DNA extraction system and others with F. Hoffmann-La Roche Ltd. (Switzerland).
1998 December Entered an OEM contract as for Automated DNA extraction system and others with Boehringer Mannheim GmbH (Germany) (currently, Roche Diagnostics Ltd. (Switzerland)).
1999 July Entered an OEM contract as for Automated DNA extraction system and others with GenoVision AS (Norway) (currently, Qiagen AS).
2000 October Entered an OEM contract as for Automated DNA extraction system and others with Magnetic Biosolution Sweden AB (Sweden).
Initial Public Offering, 2001, Feb.
Christian Era Month Description
2001 February 28 IPO at OSE NASDAQ Japan Market (currently "JASDAQ" Market)
Capital investment and development for future growth of business : 2001 to 2007
Christian Era Month Description
2001 April Head Office transferred to Matsudo-city, Chiba, where all facilities including Matsudo Research Laboratory were incorporated in the new office building.
2001 July Establishment of U.S. subsidiary, PSS Bio Instruments, Inc. (currently, Precision System Science USA. Inc., California, U.S.), and European subsidiary at Mainz, Germany, Precision System Science Europe GmbH (currently, PSSE located at Worrstadt, Germany).
2002 July Establishment of a subsidiary, Universal Bio Research Co., Ltd. (Matsudo, Chiba).
2002 August Entered an OEM contract as for Automated DNA extraction system and others with QIAGEN AS (Norway) and QIAGEN GmbH (Germany) (the contract renewed with QIAGEN Instruments AG (Switzerland)).
2004 August Entered an OEM contract as for compact immunochemical luminescence measuring system with Mitsubishi Iatron Co., Ltd. (currently, Mitsubishi Chemical Medience Corp.).
2006 May Entered an OEM contract as for Automated DNA extraction system and others with Invitrogen Corporation (U.S.) (currently, Life Technologies Corporation).
2006 July Establishment of a subsidiary, PSS Capital Co., Ltd. as an investment company of PSS group, which manages Bio Contents Fund LLP.
2006 August Entered an OEM contract as for Automated DNA extraction system and others with Beckman Coulter. Inc. (U.S.)
2007 February Entered an OEM contract as for sample purification-reaction treatment system with NanoString Technologies, Inc. (U.S.)
2007 July Entered a domestic exclusive-sale agreement concerning automated protein purification apparatus and its reagent kit (Purelumn system) with GE Healthcare Bioscience K.K.
U.S. subsidiary PSS Bio Instruments Inc. renamed Precision System Science USA, Inc.
Gaining profitability and growth through selection and concentration : 2008 to now
Christian Era Month Description
2008 April Entered a collaboration with Diagenode SA (Belgium) and Nippon Gene Co., Ltd. in development of automated system for epigenetics.
2009 September PSS invested in NPS Co., Ltd. (affiliated company accounted for by the equity method) and collaboration agreement with Nippon Pulse Motor Co., Ltd.
Entered a sales and maintenance agreement with a U.S. clinical testing center, ARUP laboratories.
2010 October We moved to JASDAQ(Standard) Listed market.
2011 April PSS reaches an agreement with DiaSorin to develop a molecular diagnostic analyzer for LAMP.
2012 March PSS reaches Development Agreement with Abbott.
2013 April PSS and ELITech Group enter into a Joint Development, Distribution and Supply Agreement on PSS's "geneLEAD", a fully automated, sample-to-result, Real-Time PCR analyzer.
August PSS and LG Life Sciences enter into a Supply and Distribution Agreement for PSS's "geneLEAD", a fully automated, sample-to-result system for NAT.
2014 May PSS and Roka Bioscience enter into an OEM Agreement on Development of Automated Molecular Diagnostics System.
October PSS reaches Agreement to Supply Abbott with Two Types of Sample Prep System.
December PSS and ELITechGroup reach OEM Agreement on "geneLEAD XII" a fully automated, sample-to-result, Real-Time PCR system.
2015 October We moved to Mothers Listed market.
  • Home
  • Technologies
  • Products
  • About PSS
  • Investor Relations
  • FAQ / Contact
TOP